Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial.

Publication

Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial.

Journal Paper/Review - Jul 26, 2023

Rubini Gimenez Maria, Scheller Bruno, Farah Ahmed, Ohlow Marc-Alexander, Mangner Norman, Weilenmann Daniel, Wöhrle Jochen, Cuculi Florim, Leibundgut Gregor, Möbius-Winkler Sven, Cattaneo Marco, Gilgen Nicole, Kaiser Christoph A, Jeger Raban V

Citation

Rubini Gimenez M, Scheller B, Farah A, Ohlow M, Mangner N, Weilenmann D, Wöhrle J, Cuculi F, Leibundgut G, Möbius-Winkler S, Cattaneo M, Gilgen N, Kaiser C, Jeger R. Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial. Clin Res Cardiol 2023

Type

Journal Paper/Review (English)

Journal

Clin Res Cardiol 2023

Publication Date

Jul 26, 2023

Issn Electronic

1861-0692

Brief description/objective

Recent data have established non-inferiority of drug-coated balloons (DCB) compared to drug-eluting stents (DES) for treatment of small-vessel coronary artery disease. Since coronary vessels in women might have anatomical and pathophysiological particularities, the safety of the DCB strategy among women compared to men needs to be assessed in more detail.